Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
lipoprotein lipase | 0.474 | 0.808 | 1.3E-09 |
|
phenotype | 0.600 | None | 0.988 | 169 | 11 | 1975 | 2019 | ||||||||
|
apolipoprotein A5 | 0.587 | 0.615 | 5.6E-10 |
|
phenotype | 0.700 | None | 0.966 | 89 | 10 | 2002 | 2020 | ||||||||
|
apolipoprotein C3 | 0.531 | 0.731 | 1.0E-02 |
|
phenotype | 0.100 | None | 0.970 | 66 | 3 | 1983 | 2020 | ||||||||
|
apolipoprotein E | 0.338 | 0.962 | 1.9E-03 |
|
phenotype | 0.400 | None | 0.979 | 47 | 12 | 1988 | 2019 | ||||||||
|
glycosylphosphatidylinositol anchored high density lipoprotein binding protein 1 | 0.686 | 0.269 | 0.14 |
|
phenotype | 0.100 | None | 0.962 | 26 | 1 | 2007 | 2020 | ||||||||
|
apolipoprotein C2 | 0.606 | 0.577 | 0.40 |
|
phenotype | 0.200 | None | 0.960 | 25 | 1 | 1992 | 2019 | ||||||||
|
apolipoprotein B | 0.453 | 0.808 | 1.9E-16 |
|
phenotype | 0.600 | None | 1.000 | 17 | 0 | 1991 | 2019 | ||||||||
|
peroxisome proliferator activated receptor alpha | 0.432 | 0.885 | 3.0E-02 |
|
phenotype | 0.400 | None | 1.000 | 17 | 1 | 2004 | 2020 | ||||||||
|
lipase maturation factor 1 | 0.769 | 0.231 | 5.1E-16 |
|
phenotype | 0.400 | None | 1.000 | 16 | 3 | 2007 | 2019 | ||||||||
|
apolipoprotein A1 | 0.429 | 0.885 | 5.5E-04 |
|
phenotype | 0.100 | None | 1.000 | 14 | 2 | 1984 | 2017 | ||||||||
|
C-reactive protein | 0.299 | 0.962 | 3.7E-03 |
|
phenotype | 0.400 | None | 0.909 | 11 | 0 | 2002 | 2019 | ||||||||
|
glucokinase regulator | 0.604 | 0.615 | 8.5E-19 |
|
phenotype | 0.490 | None | 0.909 | 11 | 3 | 2010 | 2019 | ||||||||
|
cholesteryl ester transfer protein | 0.512 | 0.731 | 1.2E-23 |
|
phenotype | 0.390 | None | 1.000 | 10 | 0 | 1994 | 2017 | ||||||||
|
leptin | 0.349 | 0.846 | 0.46 |
|
phenotype | 0.380 | None | 1.000 | 9 | 0 | 2008 | 2019 | ||||||||
|
low density lipoprotein receptor | 0.449 | 0.885 | 9.8E-24 |
|
phenotype | 0.260 | None | 0.875 | 8 | 1 | 1998 | 2019 | ||||||||
|
glutamic--pyruvic transaminase | 0.403 | 0.923 | 3.6E-19 |
|
phenotype | 0.070 | None | 0.857 | 7 | 0 | 2017 | 2019 | ||||||||
|
fatty acid binding protein 2 | 0.608 | 0.654 | 5.0E-03 |
|
phenotype | 0.070 | None | 1.000 | 7 | 1 | 2002 | 2016 | ||||||||
|
apolipoprotein A2 | 0.582 | 0.769 | 4.5E-02 |
|
phenotype | 0.060 | None | 0.833 | 6 | 0 | 1994 | 2006 | ||||||||
|
peroxisome proliferator activated receptor gamma | 0.358 | 0.885 | 2.9E-02 |
|
phenotype | 0.160 | None | 0.833 | 6 | 3 | 2006 | 2020 | ||||||||
|
cAMP responsive element binding protein 3 like 3 | 0.792 | 0.192 | 8.1E-14 |
|
phenotype | 0.060 | None | 1.000 | 6 | 2 | 2011 | 2019 | ||||||||
|
angiopoietin like 4 | 0.498 | 0.731 | 2.3E-11 |
|
phenotype | 0.350 | None | 1.000 | 6 | 0 | 2009 | 2019 | ||||||||
|
retinol binding protein 4 | 0.493 | 0.808 | 0.52 |
|
phenotype | 0.060 | None | 0.833 | 6 | 1 | 2009 | 2018 | ||||||||
|
ZPR1 zinc finger | 0.674 | 0.462 | 8.9E-09 |
|
phenotype | 0.120 | None | 1.000 | 5 | 8 | 2010 | 2017 | ||||||||
|
adiponectin, C1Q and collagen domain containing | 0.376 | 0.885 | 4.6E-09 |
|
phenotype | 0.050 | None | 1.000 | 5 | 0 | 2008 | 2018 | ||||||||
|
lipoprotein(a) like 2, pseudogene | 0.626 | 0.731 |
|
phenotype | 0.040 | None | 0.750 | 4 | 0 | 1994 | 2001 |